Treatment of Dementia due to Cerebrovascular Disease in Mild Vascular Cognitive Impairment (vMCI) with Depressive and Anxious Symptoms
Mild vascular cognitive impairment (vMCI) represents cognitive decline from a prior level of functioning that does not significantly impair basic or instrumental activities of daily living. When depressive and anxious symptoms co-occur, they constitute a clinically important target that shapes treatment selection in this population.
Clinical Scenario
The patient has mild vascular neurocognitive disorder (vMCI) — a decline in cognition from their previous baseline without marked loss of daily functioning — accompanied by co-occurring depressive and anxious symptoms. Guidelines specifically recognise this combination as warranting targeted intervention.
Treatment Approach (Partial Overview)
Management in this setting may be escalated to include pharmacological and/or non-pharmacological modalities — the appropriate approach depends on the individual's overall health state and the degree of cognitive and communication deficits present. The complete structured regimen, including sequencing and individualisation criteria, is available via the link below.
References
Mild vascular neurocognitive disorder (vascular mild cognitive impairment, vMCI) includes cognitive decline from a previous level of cognitive functioning without significant impairment of basic activities of daily living (bADLs) and/or instrumental activities of daily living (iADLs).
For patients with mild VCI it is reasonable to consider either cognitive-behavioural therapy, interpersonal therapy or behavioural activation as one of the first-line treatments for depressive and anxious symptoms, as a monotherapy.
Treatment for mood and anxiety may include psychotherapy, non-pharmacological therapies (such as exercise), and/or pharmacotherapy alone or in combination, as appropriate to the individual's health state and presence of cognitive and communication deficits.
View source ↗